SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Infinity Pharmaceuticals
An SI Board Since April 2006
Posts SubjectMarks Bans Symbol
210 13 0 INFI
Emcee:  dr.praveen Type:  Moderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10Why are they placing such a low valuation on themselves in today’s deal? Is therDewDiligence_on_SI-4/12/2006
9[PI/II trial for relapsed or refractory MM with melphalan & velcade] >&gdr.praveen-4/12/2006
8OVERVIEW OF NEW THERAPIES AND FUTURE DIRECTIONS K Anderson. Dana-Farber Cancer Idr.praveen-4/12/2006
7INFINITY adds improvisation to drug quest By Scott Kirsner | July 11, 2005 Stevdr.praveen-4/12/2006
6[Data on IPI-504 from '05 AACR meeting] >>ANAHEIM, Calif., April 20 /dr.praveen-4/12/2006
5Infinity Presents Promising Anticancer Activity of IPI-504 in Preclinical Studiedr.praveen-4/12/2006
4Infinity Initiates Phase I Clinical Trial of IPI-504 for Multiple Myeloma Investdr.praveen-4/12/2006
3Infinity Initiates Phase I Clinical Trial of IPI-504 for Patients with Gastrointdr.praveen-4/12/2006
2Infinity Announces Major Drug Discovery, Development and Commercialization Alliadr.praveen-4/12/2006
1Discovery Partners International and INFINITY PHARMACEUTICALS Announce Merger Agdr.praveen-4/12/2006
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):